4//SEC Filing
Mainolfi Nello 4
Accession 0001193125-26-004641
CIK 0001815442other
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 4:40 PM ET
Size
6.8 KB
Accession
0001193125-26-004641
Insider Transaction Report
Form 4
Mainolfi Nello
DirectorChief Executive Officer
Transactions
- Exercise/Conversion
Common Stock
2026-01-05$32.07/sh+3,118$99,994→ 666,195 total - Exercise/Conversion
Stock Option (Right to Buy)
2026-01-05−3,118→ 446,882 totalExercise: $32.07Exp: 2033-03-01→ Common Stock (3,118 underlying)
Footnotes (1)
- [F1]The shares underlying this stock option shall vest in thirty-six (36) equal monthly installments following March 1, 2023, subject to the reporting person's continued employment through each vesting date.
Documents
Issuer
Kymera Therapeutics, Inc.
CIK 0001815442
Entity typeother
Related Parties
1- filerCIK 0001821189
Filing Metadata
- Form type
- 4
- Filed
- Jan 5, 7:00 PM ET
- Accepted
- Jan 6, 4:40 PM ET
- Size
- 6.8 KB